- Home
- NCRA vs MBRX Comparison
NCRA vs MBRX Comparison
Compare NCRA & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- MBRX
- Stock Information
- Founded
- NCRA 2002
- MBRX 2015
- Country
- NCRA Taiwan
- MBRX United States
- Employees
- NCRA N/A
- MBRX N/A
- Industry
- NCRA Farming/Seeds/Milling
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- MBRX Health Care
- Exchange
- NCRA Nasdaq
- MBRX Nasdaq
- Market Cap
- NCRA 15.1M
- MBRX 12.9M
- IPO Year
- NCRA N/A
- MBRX 2016
- Fundamental
- Price
- NCRA $1.74
- MBRX $0.59
- Analyst Decision
- NCRA
- MBRX Strong Buy
- Analyst Count
- NCRA 0
- MBRX 3
- Target Price
- NCRA N/A
- MBRX $5.33
- AVG Volume (30 Days)
- NCRA 57.7K
- MBRX 9.4M
- Earning Date
- NCRA 08-13-2025
- MBRX 08-13-2025
- Dividend Yield
- NCRA N/A
- MBRX N/A
- EPS Growth
- NCRA N/A
- MBRX N/A
- EPS
- NCRA N/A
- MBRX N/A
- Revenue
- NCRA $16,647,379.00
- MBRX N/A
- Revenue This Year
- NCRA N/A
- MBRX N/A
- Revenue Next Year
- NCRA N/A
- MBRX N/A
- P/E Ratio
- NCRA N/A
- MBRX N/A
- Revenue Growth
- NCRA N/A
- MBRX N/A
- 52 Week Low
- NCRA $0.70
- MBRX $0.25
- 52 Week High
- NCRA $2.09
- MBRX $3.67
- Technical
- Relative Strength Index (RSI)
- NCRA 84.15
- MBRX 48.04
- Support Level
- NCRA $1.00
- MBRX $0.53
- Resistance Level
- NCRA $1.70
- MBRX $0.96
- Average True Range (ATR)
- NCRA 0.11
- MBRX 0.11
- MACD
- NCRA 0.07
- MBRX -0.00
- Stochastic Oscillator
- NCRA 100.00
- MBRX 20.19
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.